These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
715 related items for PubMed ID: 25092439
21. Schistosoma mansoni SmKI-1 or Its C-Terminal Fragment Induces Partial Protection Against S. mansoni Infection in Mice. Morais SB, Figueiredo BC, Assis NRG, Homan J, Mambelli FS, Bicalho RM, Souza C, Martins VP, Pinheiro CS, Oliveira SC. Front Immunol; 2018; 9():1762. PubMed ID: 30105029 [Abstract] [Full Text] [Related]
28. Process development for production and purification of the Schistosoma mansoni Sm14 antigen. Damasceno L, Ritter G, Batt CA. Protein Expr Purif; 2017 Jun 30; 134():72-81. PubMed ID: 28389350 [Abstract] [Full Text] [Related]
31. Refolding of the recombinant protein Sm29, a step toward the production of the vaccine candidate against schistosomiasis. Chura-Chambi RM, Nakajima E, de Carvalho RR, Miyasato PA, Oliveira SC, Morganti L, Martins EA. J Biotechnol; 2013 Dec 30; 168(4):511-9. PubMed ID: 24084635 [Abstract] [Full Text] [Related]
33. A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine. Tendler M, Brito CA, Vilar MM, Serra-Freire N, Diogo CM, Almeida MS, Delbem AC, Da Silva JF, Savino W, Garratt RC, Katz N, Simpson AS. Proc Natl Acad Sci U S A; 1996 Jan 09; 93(1):269-73. PubMed ID: 8552619 [Abstract] [Full Text] [Related]
34. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni. Allam G. Immunobiology; 2009 Jan 09; 214(8):712-27. PubMed ID: 19249123 [Abstract] [Full Text] [Related]
35. Tandem repeat recombinant proteins as potential antigens for the sero-diagnosis of Schistosoma mansoni infection. Kalenda YD, Kato K, Goto Y, Fujii Y, Hamano S. Parasitol Int; 2015 Dec 09; 64(6):503-12. PubMed ID: 26148816 [Abstract] [Full Text] [Related]
36. DNA vaccination using recombinant Schistosoma mansoni fatty acid binding protein (smFABP) gene. Aly I, ELnain G, Hamad RS, Kilany M, Ghramh HA, Alshehri A, Dajem SM, Ibrahim EH. Exp Parasitol; 2018 Nov 09; 194():53-59. PubMed ID: 30266572 [Abstract] [Full Text] [Related]
37. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice. Preyavichyapugdee N, Sahaphong S, Riengrojpitak S, Grams R, Viyanant V, Sobhon P. Exp Parasitol; 2008 Jun 09; 119(2):229-37. PubMed ID: 18329021 [Abstract] [Full Text] [Related]
38. Human IgG1 and IgG3 recognition of Schistosoma mansoni 14kDa fatty acid-binding recombinant protein. Brito CF, Fonseca CT, Goes AM, Azevedo V, Simpson AJ, Oliveira SC. Parasite Immunol; 2000 Jan 09; 22(1):41-8. PubMed ID: 10744504 [Abstract] [Full Text] [Related]
39. Oral immunization of mice against Schistosoma mansoni using drinking water from trays containing Biomphalaria alexandrina infected with Schistosoma mansoni. Noureldin MS. J Egypt Soc Parasitol; 1999 Jan 09; 29(1):167-77. PubMed ID: 12561896 [Abstract] [Full Text] [Related]